Clostridium Difficile Infection Associated With Higher Mortality Rates in Patients With Cirrhosis
Clostridium difficile infection leads to higher rates of overall mortality among patients with cirrhosis compared to those who do not have the condition.
Mood-Altering Medications Do Not Increase Risk for Post-TIPS Hepatic Encephalopathy
The use of mood-altering medications does not increase odds for hepatic encephalopathy or hepatic encephalopathy-related hospital admissions after TIPS placement, according to the results of a new study.
Higher Dose of Simvastatin Leads to Increased Toxicity for Patients With Decompensated Cirrhosis
Data from a phase 2, double-blind, placebo-controlled study, showed a higher dose of simvastatin was associated with greater liver and muscle toxicity compared with a lower dose for patients with decompensated cirrhosis.
2 Clarke Drive Cranbury, NJ 08512